Definigen Investors
Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.
Investors
Founded Date:
2012
Number Of Exists:
Venture - Series Unknown
Industry:
Healthcare Innovations
Investor Type:
Healthcare Company
Employee Number:
11-50

%20.jpg)




%20.jpg)




